Physician profile
Harlan I Wright
NPI 1386653590
$24,287.08
in general payments reported to CMS, 2019-2025
12 companies · $220 in 2025
The $220 reported for 2025 was less than what a typical Hepatology provider received nationally (typical 2025 total: $981).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $7,972 · 2021: $405 · 2024: $300 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $520.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $23,468.99 | 2019-2025 | |
| Incyte Corporation | $230.16 | 2019-2025 | Niktimvo |
| Abbvie INC. | $172.02 | 2019-2020 | |
| Veloxis Pharmaceuticals, INC. | $127.49 | 2019-2025 | Envarsus |
| Ipsen Biopharmaceuticals, INC | $101.94 | 2024-2025 | Iqirvo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.11 | 2019-2024 | Xifaxan |
| Intercept Pharmaceuticals, INC. | $44.97 | 2019-2020 | |
| Genzyme Corporation | $33.95 | 2019 | |
| Eisai INC. | $18.57 | 2019 | |
| Mallinckrodt Hospital Products INC. | $14.73 | 2024 | Terlivaz |
| Alexion Pharmaceuticals, INC. | $14.58 | 2019 | |
| Dova Pharmaceuticals | $13.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harlan Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.